VanEck Pharmaceutical ETF
PPH
PPH
45 hedge funds and large institutions have $85.5M invested in VanEck Pharmaceutical ETF in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
10
Reduced
14
Closed
8
Calls
$496K
Puts
–
Net Calls
+$496K
Net Calls Change
+$1.54M
Top Buyers
| 1 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$8.05M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.12M |
| 3 |
Cerity Partners
New York
|
+$1.16M |
| 4 |
FA
Fortis Advisors
Wayne,
Pennsylvania
|
+$686K |
| 5 |
NL
NVWM LLC
Yardley,
Pennsylvania
|
+$438K |
Top Sellers
| 1 |
Citigroup
New York
|
-$11.3M |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$5.98M |
| 3 |
Goldman Sachs
New York
|
-$5.49M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$4.6M |
| 5 |
SG Americas Securities
New York
|
-$3.22M |